Cosmos Health Inc.
COSM Nasdaq· Wholesale-Drugs, Proprietaries & Druggists' Sundries
Last close · Oct 23, 2026
$0.26
KIRA · Stoqly’s AI analyst, in plain words
- Cosmos Health Inc. had $65.3M of revenue in fiscal 2025, up 19.9% on the year before. Over five years, revenue changed +3.3% a year on average.
- Its operating margin was −25.6%, up 3.0 pts: of every 100 in sales, about −26 is left after running the business.
- Cosmos Health Inc. lost $19.1M in fiscal 2025.
- Free cash flow was −$8.5M in fiscal 2025, −13.0% of revenue.
- Cosmos Health Inc. owes $3.0M more than it holds in cash.
Market cap
$15.6M
P/E
—
Revenue
$65.3M
Net income
−$19.1M
Free cash flow
−$8.5M
Operating margin
−25.6%
Cosmos Health Inc. in 30 seconds · fiscal 2025
Are sales growing?
+19.9%
Yes. Sales grew 19.9% last year.
Does it make a profit?
−29.3%
No. It lost money last year.
Does profit turn into cash?
−13.0%
No. It spent more cash than it brought in.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Cosmos Health Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Apr 15, 2026
- Legal name
- Cosmos Health Inc.
- CIK
- 0001474167
Cosmos Health Inc. · COSM
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $56.2M | $50.3M | $53.4M | $54.4M | $65.3M |
| Revenue growth | 1.5% | −10.5% | 6.0% | 2.0% | 19.9% |
| Gross margin | 14.8% | 11.8% | 8.1% | 7.9% | 12.1% |
| Operating margin | −8.1% | −14.8% | −40.9% | −28.6% | −25.6% |
| Net income | −$8.0M | −$13.8M | −$18.5M | −$16.2M | −$19.1M |
| Net margin | −14.2% | −27.5% | −34.7% | −29.7% | −29.3% |
| Diluted EPS | −$23.74 | −$33.16 | −$2.15 | −$1.17 | −$0.63 |
| Cash | |||||
| Cash from operations | −$7.1M | −$14.9M | −$15.6M | −$7.7M | −$8.4M |
| Capital expenditure | $0.6M | $0.1M | $1.3M | $0.4M | $0.1M |
| Free cash flow | −$7.7M | −$14.9M | −$16.9M | −$8.1M | −$8.5M |
| FCF margin | −13.7% | −29.7% | −31.8% | −14.9% | −13.0% |
| Share buybacks | $0.4M | — | $0.1M | $0.0M | — |
| Share count change | −95.1% | 193.5% | 520.7% | 60.0% | 58.2% |
| Debt and strength | |||||
| Cash and short-term investments | $0.3M | $20.8M | $3.9M | $0.3M | $0.8M |
| Debt incl. finance leases | $17.9M | $5.0M | $6.5M | $4.1M | $3.8M |
| Shareholders' equity | $4.4M | $39.3M | $36.0M | $24.5M | $18.4M |
| Current ratio | 1.3x | 2.6x | 1.5x | 1.0x | 1.0x |
| Interest coverage | −1.6x | −3.2x | −25.2x | −15.4x | −8.8x |
| Returns and quality | |||||
| Return on capital | −16.3% | −25.1% | −44.6% | −43.4% | −61.6% |
| Return on equity | −7,287.5% | −63.3% | −49.2% | −53.4% | −89.1% |
| Return on tangible equity | −204.5% | −165.8% | −91.3% | −133.4% | −176.4% |
| Efficiency ratio | — | 0.4% | — | — | — |
| Piotroski F-score | 4 | 2 | 2 | 3 | 5 |
| Altman Z'' | −1.5 | 0.9 | −4.3 | −7.9 | −7.9 |
Insiders bought, 12 months
$1.7M
2 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cosmos Health Inc. · COSM
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $0.26 a share, the company is worth $15.6M.
Source: SEC EDGAR XBRL filings (CIK 0001474167). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.